Last reviewed · How we verify
Administration of Regional Anesthesia — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Carbocaine | MEPIVACAINE | Eastman Kodak | Amide Local Anesthetic | Sodium channel protein type 1 subunit alpha | 1960-01-01 | |
| Carbocaine | Carbocaine | Nantes University Hospital | Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Eastman Kodak · 1 drug in Administration of Regional Anesthesia
- Nantes University Hospital · 1 drug in Administration of Regional Anesthesia
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Administration of Regional Anesthesia:
- Administration of Regional Anesthesia treatment updates — RSS
- Administration of Regional Anesthesia treatment updates — Atom
- Administration of Regional Anesthesia treatment updates — JSON
Cite this brief
Drug Landscape (2026). Administration of Regional Anesthesia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/administration-of-regional-anesthesia. Accessed 2026-06-10.
Related
- Administration of Regional Anesthesia full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing